Record Information |
---|
Version | 5.0 |
---|
Status | Detected and Quantified |
---|
Creation Date | 2005-11-16 15:48:42 UTC |
---|
Update Date | 2021-09-07 16:45:29 UTC |
---|
HMDB ID | HMDB0001389 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Melatonin |
---|
Description | Melatonin is a biogenic amine that is found in animals, plants and microbes. Aaron B. Lerner of Yale University is credited for naming the hormone and for defining its chemical structure in 1958. In mammals, melatonin is produced by the pineal gland. The pineal gland is small endocrine gland, about the size of a rice grain and shaped like a pine cone (hence the name), that is located in the center of the brain (rostro-dorsal to the superior colliculus) but outside the blood-brain barrier. The secretion of melatonin increases in darkness and decreases during exposure to light, thereby regulating the circadian rhythms of several biological functions, including the sleep-wake cycle. In particular, melatonin regulates the sleep-wake cycle by chemically causing drowsiness and. lowering the body temperature. Melatonin is also implicated in the regulation of mood,learning and memory, immune activity, dreaming, fertility and reproduction. Melatonin is also an effective antioxidant. Most of the actions of melatonin are mediated through the binding and activation of melatonin receptors. Individuals with autism spectrum disorders(ASD) may have lower than normal levels of melatonin. A 2008 study found that unaffected parents of individuals with ASD also have lower melatonin levels, and that the deficits. were associated with low activity of the ASMT gene, which encodes the last enzyme of melatonin synthesis. Reduced melatonin production has also been proposed as a likely factor in the significantly higher cancer rates in night workers. |
---|
Structure | COC1=CC2=C(NC=C2CCNC(C)=O)C=C1 InChI=1S/C13H16N2O2/c1-9(16)14-6-5-10-8-15-13-4-3-11(17-2)7-12(10)13/h3-4,7-8,15H,5-6H2,1-2H3,(H,14,16) |
---|
Synonyms | Value | Source |
---|
5-Methoxy-N-acetyltryptamine | ChEBI | Melatonine | ChEBI | N-[2-(5-Methoxyindol-3-yl)ethyl]acetamide | ChEBI | N-Acetyl-5-methoxytryptamine | ChEBI | Melatonina | Kegg | Circadin | HMDB | Melatol | HMDB | Melatonin (synth.) standard-grade | HMDB | Melatonin (synth.) ultra-pure | HMDB | Melovine | HMDB | MT6 | HMDB | N-(2-(5-Methoxy-1H-indol-3-yl)ethyl)acetamide | HMDB | N-(2-(5-Methoxyindol-3-yl)ethyl)-acetamide | HMDB | N-(2-(5-Methoxyindol-3-yl)ethyl)acetamide | HMDB | N-Acetyl-5-methoxy-tryptamine | HMDB | N-Acetyl-5-methoxy-tryptamine melatonine | HMDB | N-[2-(5-Methoxy-1H-indol-3-yl)ethyl)acetamide | HMDB | N-[2-(5-Methoxy-1H-indol-3-yl)ethyl]-acetamide | HMDB | N-[2-(5-Methoxy-1H-indol-3-yl)ethyl]acetamide | HMDB | N-[2-(5-Methoxyindol-3-yl)ethyl]-acetamide | HMDB | Regulin | HMDB | {N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-} acetamide | HMDB | {N-[2-(5-methoxyindol-3-yl)ethyl]-} acetamide | HMDB | 3-(2-Acetamidoethyl)-5-methoxyindole | HMDB | Melatonin | HMDB |
|
---|
Chemical Formula | C13H16N2O2 |
---|
Average Molecular Weight | 232.2783 |
---|
Monoisotopic Molecular Weight | 232.121177766 |
---|
IUPAC Name | N-[2-(5-methoxy-1H-indol-3-yl)ethyl]acetamide |
---|
Traditional Name | melatonin |
---|
CAS Registry Number | 73-31-4 |
---|
SMILES | COC1=CC2=C(NC=C2CCNC(C)=O)C=C1 |
---|
InChI Identifier | InChI=1S/C13H16N2O2/c1-9(16)14-6-5-10-8-15-13-4-3-11(17-2)7-12(10)13/h3-4,7-8,15H,5-6H2,1-2H3,(H,14,16) |
---|
InChI Key | DRLFMBDRBRZALE-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as 3-alkylindoles. 3-Alkylindoles are compounds containing an indole moiety that carries an alkyl chain at the 3-position. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Indoles and derivatives |
---|
Sub Class | Indoles |
---|
Direct Parent | 3-alkylindoles |
---|
Alternative Parents | |
---|
Substituents | - 3-alkylindole
- Anisole
- Alkyl aryl ether
- Substituted pyrrole
- Benzenoid
- Pyrrole
- Heteroaromatic compound
- Propargyl-type 1,3-dipolar organic compound
- Ether
- Carboximidic acid derivative
- Carboximidic acid
- Organic 1,3-dipolar compound
- Azacycle
- Organic oxygen compound
- Hydrocarbon derivative
- Organopnictogen compound
- Organic nitrogen compound
- Organooxygen compound
- Organonitrogen compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | |
---|
Disposition | |
---|
Process | |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 117 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Experimental Collision Cross Sections |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Melatonin,1TMS,isomer #1 | COC1=CC=C2C(=C1)C(CCNC(C)=O)=CN2[Si](C)(C)C | 2455.1 | Semi standard non polar | 33892256 | Melatonin,1TMS,isomer #1 | COC1=CC=C2C(=C1)C(CCNC(C)=O)=CN2[Si](C)(C)C | 2391.9 | Standard non polar | 33892256 | Melatonin,1TMS,isomer #1 | COC1=CC=C2C(=C1)C(CCNC(C)=O)=CN2[Si](C)(C)C | 2942.9 | Standard polar | 33892256 | Melatonin,1TMS,isomer #2 | COC1=CC=C2[NH]C=C(CCN(C(C)=O)[Si](C)(C)C)C2=C1 | 2337.0 | Semi standard non polar | 33892256 | Melatonin,1TMS,isomer #2 | COC1=CC=C2[NH]C=C(CCN(C(C)=O)[Si](C)(C)C)C2=C1 | 2493.9 | Standard non polar | 33892256 | Melatonin,1TMS,isomer #2 | COC1=CC=C2[NH]C=C(CCN(C(C)=O)[Si](C)(C)C)C2=C1 | 2961.8 | Standard polar | 33892256 | Melatonin,2TMS,isomer #1 | COC1=CC=C2C(=C1)C(CCN(C(C)=O)[Si](C)(C)C)=CN2[Si](C)(C)C | 2377.2 | Semi standard non polar | 33892256 | Melatonin,2TMS,isomer #1 | COC1=CC=C2C(=C1)C(CCN(C(C)=O)[Si](C)(C)C)=CN2[Si](C)(C)C | 2552.5 | Standard non polar | 33892256 | Melatonin,2TMS,isomer #1 | COC1=CC=C2C(=C1)C(CCN(C(C)=O)[Si](C)(C)C)=CN2[Si](C)(C)C | 2692.7 | Standard polar | 33892256 | Melatonin,1TBDMS,isomer #1 | COC1=CC=C2C(=C1)C(CCNC(C)=O)=CN2[Si](C)(C)C(C)(C)C | 2675.3 | Semi standard non polar | 33892256 | Melatonin,1TBDMS,isomer #1 | COC1=CC=C2C(=C1)C(CCNC(C)=O)=CN2[Si](C)(C)C(C)(C)C | 2586.8 | Standard non polar | 33892256 | Melatonin,1TBDMS,isomer #1 | COC1=CC=C2C(=C1)C(CCNC(C)=O)=CN2[Si](C)(C)C(C)(C)C | 2999.0 | Standard polar | 33892256 | Melatonin,1TBDMS,isomer #2 | COC1=CC=C2[NH]C=C(CCN(C(C)=O)[Si](C)(C)C(C)(C)C)C2=C1 | 2585.8 | Semi standard non polar | 33892256 | Melatonin,1TBDMS,isomer #2 | COC1=CC=C2[NH]C=C(CCN(C(C)=O)[Si](C)(C)C(C)(C)C)C2=C1 | 2690.6 | Standard non polar | 33892256 | Melatonin,1TBDMS,isomer #2 | COC1=CC=C2[NH]C=C(CCN(C(C)=O)[Si](C)(C)C(C)(C)C)C2=C1 | 3015.2 | Standard polar | 33892256 | Melatonin,2TBDMS,isomer #1 | COC1=CC=C2C(=C1)C(CCN(C(C)=O)[Si](C)(C)C(C)(C)C)=CN2[Si](C)(C)C(C)(C)C | 2803.8 | Semi standard non polar | 33892256 | Melatonin,2TBDMS,isomer #1 | COC1=CC=C2C(=C1)C(CCN(C(C)=O)[Si](C)(C)C(C)(C)C)=CN2[Si](C)(C)C(C)(C)C | 2933.3 | Standard non polar | 33892256 | Melatonin,2TBDMS,isomer #1 | COC1=CC=C2C(=C1)C(CCN(C(C)=O)[Si](C)(C)C(C)(C)C)=CN2[Si](C)(C)C(C)(C)C | 2857.1 | Standard polar | 33892256 |
|
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental GC-MS | GC-MS Spectrum - Melatonin GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies) (Non-derivatized) | splash10-001i-0490000000-aa93967315af900a76ce | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Melatonin GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies) (Non-derivatized) | splash10-03k9-0900000000-a15ee6def3f8d75b1231 | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Melatonin GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies) (Non-derivatized) | splash10-001j-0490000000-94ef1be9ab930060778a | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Melatonin GC-MS (2 TMS) | splash10-001i-1490000000-03e24298c7bd1ed4066a | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Melatonin GC-MS (Non-derivatized) | splash10-001i-1490000000-03e24298c7bd1ed4066a | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Melatonin GC-EI-TOF (Non-derivatized) | splash10-001j-0590000000-63d5e32dd5f7877a4402 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Melatonin GC-EI-TOF (Non-derivatized) | splash10-001i-0590000000-52b3a733f8b49582d3fb | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Melatonin GC-EI-TOF (Non-derivatized) | splash10-0229-1900000000-d81c6f617bc486066136 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Melatonin GC-MS (Non-derivatized) - 70eV, Positive | splash10-0076-4920000000-a8d9d614e9f8769a1359 | 2017-08-28 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Melatonin GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Melatonin GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | MS | Mass Spectrum (Electron Ionization) | splash10-03k9-1900000000-45ee4fdc7acdb33dad3b | 2014-09-20 | Not Available | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Melatonin LC-ESI-QQ (API3000, Applied Biosystems) 20V, Negative-QTOF | splash10-0159-0090000000-939a1caf5760c0ba189c | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Melatonin LC-ESI-QQ (API3000, Applied Biosystems) 30V, Negative-QTOF | splash10-0006-0930000000-9e6fcea2c634ac9d85a0 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Melatonin LC-ESI-QQ (API3000, Applied Biosystems) 40V, Negative-QTOF | splash10-0006-0900000000-ddd29e731a7de56c1808 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Melatonin LC-ESI-QQ (API3000, Applied Biosystems) 50V, Negative-QTOF | splash10-0006-0900000000-34b4fb52810a15ea5bd6 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Melatonin LC-ESI-QQ (API3000, Applied Biosystems) 10V, Negative-QTOF | splash10-001i-0090000000-5ca2df63ec2baefdae8c | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Melatonin LC-ESI-QQ , negative-QTOF | splash10-0159-0090000000-939a1caf5760c0ba189c | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Melatonin LC-ESI-QQ , negative-QTOF | splash10-0006-0930000000-9e6fcea2c634ac9d85a0 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Melatonin LC-ESI-QQ , negative-QTOF | splash10-0006-0900000000-ddd29e731a7de56c1808 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Melatonin LC-ESI-QQ , negative-QTOF | splash10-0006-0900000000-34b4fb52810a15ea5bd6 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Melatonin LC-ESI-QQ , negative-QTOF | splash10-001i-0090000000-5ca2df63ec2baefdae8c | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Melatonin LC-ESI-QTOF , negative-QTOF | splash10-00lr-0090000000-3c42f6997539afb44682 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Melatonin LC-ESI-QTOF , negative-QTOF | splash10-014m-0960000000-7991e64dacb3c7f5cf32 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Melatonin LC-ESI-QTOF , negative-QTOF | splash10-0006-0900000000-882be43bc196e928a3cf | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Melatonin , negative-QTOF | splash10-014i-0190000000-ddda9232f0e8e1b402f7 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Melatonin 60V, Negative-QTOF | splash10-0006-0900000000-24977ebbbf8d80633142 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Melatonin 10V, Negative-QTOF | splash10-02u0-0960000000-a53f0bcd21c20cd44cfa | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Melatonin 35V, Negative-QTOF | splash10-00kf-0950000000-58b73ecf5d765d8f6c01 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Melatonin 15V, Negative-QTOF | splash10-0159-0090000000-de8a238bc05d176027cf | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Melatonin 20V, Negative-QTOF | splash10-00kf-0910000000-9996bcba8fb3d61347d4 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Melatonin 75V, Negative-QTOF | splash10-0006-0900000000-a290024caadd7d64fe8f | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Melatonin 90V, Negative-QTOF | splash10-0006-0900000000-8be298c9d42d7769f129 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Melatonin 40V, Negative-QTOF | splash10-0006-0900000000-a041de616cbb390bca58 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Melatonin 40V, Negative-QTOF | splash10-0006-0900000000-d7ba873af42444fb4b0a | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Melatonin 20V, Negative-QTOF | splash10-00kf-1940000000-9556b19d359c6c0f9d66 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Melatonin 35V, Negative-QTOF | splash10-014i-0190000000-6462edd7b08702e1f49e | 2021-09-20 | HMDB team, MONA | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Experimental 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, experimental) | 2012-12-04 | Wishart Lab | View Spectrum | Experimental 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, H2O, experimental) | 2012-12-05 | Wishart Lab | View Spectrum |
|
---|
Biological Properties |
---|
Cellular Locations | |
---|
Biospecimen Locations | - Blood
- Cerebrospinal Fluid (CSF)
- Saliva
- Urine
|
---|
Tissue Locations | - Adipose Tissue
- Adrenal Cortex
- Adrenal Gland
- Adrenal Medulla
- Bladder
- Brain
- Fibroblasts
- Intestine
- Kidney
- Leukocyte
- Liver
- Neuron
- Ovary
- Pancreas
- Pineal Gland
- Placenta
- Platelet
- Prostate
- Testis
|
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0.00019 +/- 0.00015 uM | Newborn (0-30 days old) | Both | Normal | | details | Blood | Detected and Quantified | 0.00006 +/- 0.000015 uM | Adult (>18 years old) | Female | Normal | | details | Blood | Detected and Quantified | 0.000063 +/- 0.000026 uM | Adult (>18 years old) | Male | Normal | | details | Blood | Detected and Quantified | 0.00256 +/- 0.00168 uM | Infant (0-1 year old) | Male | Normal | | details | Blood | Detected and Quantified | 0.000210 +/- 5.635e-05 uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0.00006 +/- 0.000015 uM | Newborn (0-30 days old) | Male | Normal | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.0279 (0.00-0.0558) uM | Adult (>18 years old) | Both | Normal | | details | Saliva | Detected and Quantified | 0.191 +/- 0.201 uM | Adult (>18 years old) | Female | Normal | | details | Urine | Detected and Quantified | 0.0000033 (0.0000006-0.000006) umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details | Urine | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details |
|
---|
Abnormal Concentrations |
---|
| |
Blood | Detected and Quantified | 0.00140 +/- 0.00103 uM | Adult (>18 years old) | Both | Uremia | | details | Urine | Detected and Quantified | 0.00210 umol/mmol creatinine | Adult (>18 years old) | Female | Pregnancy | | details |
|
---|
Associated Disorders and Diseases |
---|
Disease References | Uremia |
---|
- Vanholder R, De Smet R, Glorieux G, Argiles A, Baurmeister U, Brunet P, Clark W, Cohen G, De Deyn PP, Deppisch R, Descamps-Latscha B, Henle T, Jorres A, Lemke HD, Massy ZA, Passlick-Deetjen J, Rodriguez M, Stegmayr B, Stenvinkel P, Tetta C, Wanner C, Zidek W: Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int. 2003 May;63(5):1934-43. doi: 10.1046/j.1523-1755.2003.00924.x. [PubMed:12675874 ]
|
|
---|
Associated OMIM IDs | None |
---|
External Links |
---|
DrugBank ID | DB01065 |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | FDB004234 |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | 872 |
---|
KEGG Compound ID | C01598 |
---|
BioCyc ID | N-ACETYL-5-METHOXY-TRYPTAMINE |
---|
BiGG ID | 37965 |
---|
Wikipedia Link | Melatonin |
---|
METLIN ID | 73 |
---|
PubChem Compound | 896 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 16796 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | MELATN |
---|
MarkerDB ID | MDB00000319 |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Helmut M. Hügel and Faizul Nurlawis. Short synthesis of melatonin. Heterocycles (2003), Vol. 60, No. 10, pp. 2349 - 2354. |
---|
Material Safety Data Sheet (MSDS) | Download (PDF) |
---|
General References | - Slominski A, Pisarchik A, Zbytek B, Tobin DJ, Kauser S, Wortsman J: Functional activity of serotoninergic and melatoninergic systems expressed in the skin. J Cell Physiol. 2003 Jul;196(1):144-53. [PubMed:12767050 ]
- Boutin JA, Audinot V, Ferry G, Delagrange P: Molecular tools to study melatonin pathways and actions. Trends Pharmacol Sci. 2005 Aug;26(8):412-9. [PubMed:15992934 ]
- Christofides J, Bridel M, Egerton M, Mackay GM, Forrest CM, Stoy N, Darlington LG, Stone TW: Blood 5-hydroxytryptamine, 5-hydroxyindoleacetic acid and melatonin levels in patients with either Huntington's disease or chronic brain injury. J Neurochem. 2006 May;97(4):1078-88. Epub 2006 Mar 29. [PubMed:16573644 ]
- Drake MJ, Mills IW, Noble JG: Melatonin pharmacotherapy for nocturia in men with benign prostatic enlargement. J Urol. 2004 Mar;171(3):1199-202. [PubMed:14767300 ]
- Lahiri DK, Chen D, Lahiri P, Rogers JT, Greig NH, Bondy S: Melatonin, metals, and gene expression: implications in aging and neurodegenerative disorders. Ann N Y Acad Sci. 2004 Dec;1035:216-30. [PubMed:15681810 ]
- Bangha E, Lauth D, Kistler GS, Elsner P: Daytime serum levels of melatonin after topical application onto the human skin. Skin Pharmacol. 1997;10(5-6):298-302. [PubMed:9449169 ]
- Bubenik GA: Localization, physiological significance and possible clinical implication of gastrointestinal melatonin. Biol Signals Recept. 2001 Nov-Dec;10(6):350-66. [PubMed:11721091 ]
- Abdel-Wahhab MA, Abdel-Galil MM, El-Lithey M: Melatonin counteracts oxidative stress in rats fed an ochratoxin A contaminated diet. J Pineal Res. 2005 Mar;38(2):130-5. [PubMed:15683468 ]
- Chen HM, Hsu JT, Chen JC, Ng CJ, Chiu DF, Chen MF: Delayed neutrophil apoptosis attenuated by melatonin in human acute pancreatitis. Pancreas. 2005 Nov;31(4):360-4. [PubMed:16258371 ]
- Fabis M, Pruszynska E, Mackowiak P: In vivo and in situ action of melatonin on insulin secretion and some metabolic implications in the rat. Pancreas. 2002 Aug;25(2):166-9. [PubMed:12142740 ]
- Messner M, Huether G, Lorf T, Ramadori G, Schworer H: Presence of melatonin in the human hepatobiliary-gastrointestinal tract. Life Sci. 2001 Jun 22;69(5):543-51. [PubMed:11510949 ]
- Nishida S: Metabolic effects of melatonin on oxidative stress and diabetes mellitus. Endocrine. 2005 Jul;27(2):131-6. [PubMed:16217126 ]
- Peschke E, Frese T, Chankiewitz E, Peschke D, Preiss U, Schneyer U, Spessert R, Muhlbauer E: Diabetic Goto Kakizaki rats as well as type 2 diabetic patients show a decreased diurnal serum melatonin level and an increased pancreatic melatonin-receptor status. J Pineal Res. 2006 Mar;40(2):135-43. [PubMed:16441550 ]
- Reiter RJ, Sainz RM, Lopez-Burillo S, Mayo JC, Manchester LC, Tan DX: Melatonin ameliorates neurologic damage and neurophysiologic deficits in experimental models of stroke. Ann N Y Acad Sci. 2003 May;993:35-47; discussion 48-53. [PubMed:12853293 ]
- Okatani Y, Wakatsuki A, Shinohara K, Kaneda C, Fukaya T: Melatonin stimulates glutathione peroxidase activity in human chorion. J Pineal Res. 2001 May;30(4):199-205. [PubMed:11339508 ]
- Bubenik GA: Gastrointestinal melatonin: localization, function, and clinical relevance. Dig Dis Sci. 2002 Oct;47(10):2336-48. [PubMed:12395907 ]
- Wurtman RJ, Ozaki Y: Physiological control of melatonin synthesis and secretion: mechanisms, generating rhythms in melatonin, methoxytryptophol, and arginine vasotocin levels and effects on the pineal of endogenous catecholamines, the estrous cycle, and environmental lighting. J Neural Transm Suppl. 1978;(13):59-70. [PubMed:288858 ]
- Kobayashi H, Kromminga A, Dunlop TW, Tychsen B, Conrad F, Suzuki N, Memezawa A, Bettermann A, Aiba S, Carlberg C, Paus R: A role of melatonin in neuroectodermal-mesodermal interactions: the hair follicle synthesizes melatonin and expresses functional melatonin receptors. FASEB J. 2005 Oct;19(12):1710-2. Epub 2005 Jul 19. [PubMed:16030176 ]
- Johe PD, Osterud B: The in vivo effect of melatonin on cellular activation processes in human blood during strenuous physical exercise. J Pineal Res. 2005 Oct;39(3):324-30. [PubMed:16150115 ]
- Paakkonen T, Makinen TM, Leppaluoto J, Vakkuri O, Rintamaki H, Palinkas LA, Hassi J: Urinary melatonin: a noninvasive method to follow human pineal function as studied in three experimental conditions. J Pineal Res. 2006 Mar;40(2):110-5. [PubMed:16441547 ]
- Atkinson G, Holder A, Robertson C, Gant N, Drust B, Reilly T, Waterhouse J: Effects of melatonin on the thermoregulatory responses to intermittent exercise. J Pineal Res. 2005 Nov;39(4):353-9. [PubMed:16207290 ]
- Hattori A, Migitaka H, Iigo M, Itoh M, Yamamoto K, Ohtani-Kaneko R, Hara M, Suzuki T, Reiter RJ: Identification of melatonin in plants and its effects on plasma melatonin levels and binding to melatonin receptors in vertebrates. Biochem Mol Biol Int. 1995 Mar;35(3):627-34. [PubMed:7773197 ]
- Reiter RJ, Acuna-Castroviejo D, Tan DX, Burkhardt S: Free radical-mediated molecular damage. Mechanisms for the protective actions of melatonin in the central nervous system. Ann N Y Acad Sci. 2001 Jun;939:200-15. [PubMed:11462772 ]
- Caniato R, Filippini R, Piovan A, Puricelli L, Borsarini A, Cappelletti EM: Melatonin in plants. Adv Exp Med Biol. 2003;527:593-7. [PubMed:15206778 ]
- Hardeland R: Antioxidative protection by melatonin: multiplicity of mechanisms from radical detoxification to radical avoidance. Endocrine. 2005 Jul;27(2):119-30. [PubMed:16217125 ]
- Ma X, Chen C, Krausz KW, Idle JR, Gonzalez FJ: A metabolomic perspective of melatonin metabolism in the mouse. Endocrinology. 2008 Apr;149(4):1869-79. doi: 10.1210/en.2007-1412. Epub 2008 Jan 10. [PubMed:18187545 ]
|
---|